Clinical Trials Directory

Trials / Completed

CompletedNCT00715416

PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents

Balloon Angioplasty vs. Primary Stenting of Femoropopliteal Arteries Using Self-Expandable Nitinol Stents - a Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Vienna General Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The investigators evaluated whether primary implantation of a self-expanding nitinol stent yielded anatomical and clinical benefits superior to those afforded by percutaneous transluminal angioplasty with optional secondary stenting.

Conditions

Interventions

TypeNameDescription
DEVICENitinol stentInterventions are performed percutaneously from either an antegrade or an over-the-bifurcation approach. After insertion of an 6 French sheath, 5000 IU of heparin are administered intra-arterially. After passage of the stenosis/occlusion with the guide wire, patients are randomized to either PTA or primary stent implantation. For standardized documentation of the lesion morphology and comparability during follow-up, a ruler is fixed at the patients thigh with the distal end exactly overlapping at the upper edge of the patella. As a bail-out procedure in the PTA group, stent placement is performed in cases with a residual stenosis of more than 30% in the worst view angiogram.
PROCEDURENitinol Stent PlacementBalloon angioplasty compared to primary stent implantation for long segment superficial femoral artery lesions

Timeline

Start date
2004-06-01
Primary completion
2008-02-01
Completion
2008-02-01
First posted
2008-07-15
Last updated
2008-07-15

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00715416. Inclusion in this directory is not an endorsement.